Copayment Adjustments Under Bundled and Two-Tiered Pricing: Welfare Implications for Outpatient Care in Taiwanese Hospitals
Author:
Open Access
- 31 August 2025
- journal article
- Published by SAGE Publications in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
- Vol. 62
Abstract
This study investigates the welfare implications of copayment adjustments on non-prescription drug services and prescription drugs provided through outpatient care in Taiwan’s hospitals under the bundled and 2-tiered pricing scheme. The novelty of this study lies in its analysis of the welfare effects of outpatient copayments under this pricing structure. Structural change models were employed to estimate the welfare effects of copayment adjustments. The analysis reveals that higher copayments prior to physician consultations may lead to a pricing-out effect for low-income individuals in medical centers, while the impact is negligible in regional hospitals. The estimated willingness-to-pay (WTP) for an outpatient visit involving regular and refillable prescription drugs in medical centers is approximately NT$2024 (95% CI: [1978, 2072]) and NT$2312 (95% CI: [2267, 2357]), respectively. These values are 1.71 to 1.87 times higher than the WTP for comparable outpatient visits in regional hospitals, with estimates for regular (NT$1078; 95% CI: [1045, 1111]) and refillable prescription drugs (NT$1353; 95% CI: [1304, 1400]). The WTP for prescription drugs bundled within an outpatient visit ranges from NT$939 (95% CI: [908, 971]) to NT$1210 (95% CI: [1174, 1244]) in medical centers and from NT$308 (95% CI: [293, 322]) to NT$544 (95% CI: [514, 574]) in regional hospitals. Additionally, the share of deadweight loss (DWL) per outpatient visit attributable to regular prescription drugs (with a cost-sharing scheme) ranges from 14.58% to 31.15%, which is significantly lower than that attributable to refillable prescription drugs (without a cost-sharing scheme), ranging from 17.32% to 42.80%. Our findings highlight the underestimation of welfare effects from copayment policy changes and emphasize the 2-tiered scheme as an effective approach to mitigating DWL in outpatient care utilization in Taiwan’s hospitals.Keywords
Funding Information
- Taiwan National Science and Technology Council (112-2410-H-025-011/113-2410-H-025-06)
This publication has 41 references indexed in Scilit:
- Tiered co-payments, pricing, and demand in reference price markets for pharmaceuticalsJournal of Health Economics, 2017
- The impact of copayments on mental healthcare utilization: a natural experimentThe European Journal of Health Economics, 2017
- Doctor-Shopping Behaviors among Traditional Chinese Medicine Users in TaiwanInternational Journal of Environmental Research and Public Health, 2015
- Assessing the effectiveness of health care cost containment measures: evidence from the market for rehabilitation careInternational Journal of Health Care Finance and Economics, 2013
- How does copayment for health care services affect demand, health and redistribution? A systematic review of the empirical evidence from 1990 to 2011The European Journal of Health Economics, 2013
- Pricing-out effect from possible user-fee policies under Taiwan’s National Health InsuranceExpert Review of Pharmacoeconomics & Outcomes Research, 2010
- The impact of nonreferral outpatient co-payment on medical care utilization and expenditures in TaiwanResearch in Social and Administrative Pharmacy, 2009
- The new co-payment policy under Taiwan’s National Health Insurance: welfare gain or welfare loss?Expert Review of Pharmacoeconomics & Outcomes Research, 2008
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)Epidemiology, 2007
- The effects of outpatient co-payment policy on healthcare usage by the elderly in TaiwanArchives of Gerontology and Geriatrics, 2006